≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other lesions of median nerve

DOID EFO Endpoint Browser PheWeb

G6_MEDLEOTH

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — G56.1
  • Hospital discharge: ICD-9 — 3541
  • Hospital discharge: ICD-8 — 35701
  • Cause of death: ICD-10 — G56.1
  • Cause of death: ICD-9 — 3541
  • Cause of death: ICD-8 — 35701

2 out of 7 registries used, show all original rules.

1036

4. Check minimum number of events

None

1036

5. Include endpoints

None

1036

6. Filter based on genotype QC (FinnGen only)

1036

Control definitions (FinnGen only)

Control exclude
G6_NERPLEX

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G56
Name in latin
Alia morbositas nervi mediani

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 9440 6480 2874
Only index persons 7476 5256 2220
Unadjusted period prevalence (%)
Whole population 0.15 0.19 0.08
Only index persons 0.16 0.19 0.08
Median age at first event (years)
Whole population 50.58 50.84 49.78
Only index persons 48.51 49.05 47.24

-FinnGen-

Key figures

All Female Male
Number of individuals 1036 698 338
Unadjusted period prevalence (%) 0.21 0.24 0.15
Median age at first event (years) 46.45 45.75 47.89

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
940
Matched controls
9399
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
35701
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Nervi mediani
+∞
323.0
512
*
G56.1
ICD-10 Finland
Other lesions of median nerve
2249.1
323.0
394
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
51.8
239.0
287
79
ACC51
NOMESCO Finland
Release of median nerve
1193.8
202.9
191
*
2402
FHL
External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)
252.4
148.7
149
7
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
145.3
109.8
115
9
3540A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome
+∞
66.4
63
*
G56.2
ICD-10 Finland
Lesion of ulnar nerve
44.4
56.9
70
17
N03AX16
ATC
pregabalin; oral
3.3
50.2
317
1249
N03AX12
ATC
gabapentin; oral
3.9
47.6
225
700
N02AX02
ATC
tramadol; systemic, rectal
2.7
43.7
483
2676
3541A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Other lesion of median nerve
+∞
39.9
38
*
ACC53
NOMESCO Finland
Release of ulnar nerve
203.1
38.1
39
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
31.8
472
2876
M48.0
ICD-10 Finland
Spinal stenosis
3.1
27.7
175
653
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.5
26.2
132
418
XA402
NOMESCO Finland
ENMG
12.0
25.7
47
41
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.4
25.6
265
1322
N06AA09
ATC
amitriptyline; systemic
3.2
24.4
141
494
M79.6
ICD-10 Finland
Pain in limb
2.1
24.1
375
2245
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
23.3
245
1222
N02BE01
ATC
paracetamol; systemic, rectal
2.6
23.3
830
6994
M01AC06
ATC
meloxicam; systemic, rectal
2.1
23.2
392
2415
G54.0
ICD-10 Finland
Brachial plexus disorders
28.1
22.3
30
11
M03BX02
ATC
tizanidine; oral
1.9
21.3
555
4001
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
8.1
21.2
48
62
G56.3
ICD-10 Finland
Lesion of radial nerve
78.6
20.8
23
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.7
20.2
147
595
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.5
19.4
174
790
WX120
NOMESCO Finland
Intravenous local anesthesy of arm
16.0
19.4
31
20
M01AE02
ATC
naproxen; oral, rectal
1.9
18.9
516
3712
M01AB05
ATC
diclofenac; systemic, rectal
1.9
18.7
608
4639
N06AX21
ATC
duloxetine; oral
3.0
18.7
115
418
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
18.6
165
746
M25.5
ICD-10 Finland
Pain in joint
2.0
18.0
266
1520
L11
ICPC
Wrist symptom/complaint
3.3
17.7
92
297
M01AH05
ATC
etoricoxib; oral
1.8
17.3
529
3903
M65.3
ICD-10 Finland
Trigger finger
4.8
17.1
58
128
9502
FHL
Tendon splitting (De Quervain, click finger)
23.5
16.5
23
10
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
3.2
16.3
87
287
S18
ICPC
Laceration/cut
1.8
16.0
400
2734
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
15.9
298
1846
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
3.7
15.9
71
203
M02AA07
ATC
piroxicam; topical
1.8
15.8
383
2588
H02AB06
ATC
prednisolone; systemic
1.8
15.8
449
3198
L03
ICPC
Low back symptom/complaint
2.0
15.7
242
1393
M54.5
ICD-10 Finland
Low back pain
1.9
15.6
313
1983
ZXA00
NOMESCO Finland
Right side
1.9
15.1
281
1733
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
14.6
211
1181
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
3.3
14.4
73
232
M01AX17
ATC
nimesulide; oral
1.9
14.2
262
1604
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.2
13.9
158
799
L12
ICPC
Hand/finger symptom/complaint
2.3
13.9
142
681
J01AA02
ATC
doxycycline; systemic
1.8
13.7
718
6033
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
13.6
362
2488
SPAT1153
SPAT
Removal of sutures
1.8
13.5
315
2077
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
5.6
13.3
38
70
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.9
13.2
82
300
WX204
NOMESCO Finland
Axillary plexus blockaced
5.1
13.2
41
83
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
2.9
13.1
80
289
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.6
13.1
98
401
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
7.3
12.8
30
42
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
12.8
86
330
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
12.7
173
942
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.3
12.7
125
590
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.8
12.6
82
308
G51.0
ICD-10 Finland
Bell palsy
32.5
12.6
16
5
R03AC02
ATC
salbutamol; inhalant
1.7
12.6
467
3510
ACC52
NOMESCO Finland
Release of radial nerve
+∞
12.5
12
*
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.0
12.5
50
131
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
4.3
12.4
46
112
SPAT1263
SPAT
Sampling
1.7
12.4
391
2808
J01DA01
ATC
[U] cefalexin; systemic
1.6
12.1
569
4535
G56.4
ICD-10 Finland
Causalgia
47.3
11.9
14
*
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.9
11.8
72
260
SPAT1254
SPAT
Administration of medicine
2.0
11.8
166
914
1220
FHL
Arthroscopy
3.5
11.7
54
160
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
11.6
315
2152
R4120
NOMESCO Finland
Occupational therapy
2.9
11.5
72
265
M01AH01
ATC
celecoxib; oral (coxibs)
1.9
11.3
190
1114
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.6
11.2
38
85
M18.1
ICD-10 Finland
Other primary arthrosis of first carpometacarpal joint
5.8
11.2
31
55
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.4
11.2
54
166
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
20.3
11.1
16
8
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
11.1
105
484
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
2.3
11.0
110
522
R06.0
ICD-10 Finland
Dyspnoea
1.7
11.0
252
1634
WX110
NOMESCO Finland
Local anesthesy
1.6
11.0
568
4585
M01AH02
ATC
rofecoxib; oral
2.0
11.0
147
793
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
10.9
254
1652
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.1
10.8
41
103
G57.6
ICD-10 Finland
Lesion of plantar nerve
9.7
10.8
21
22
C03CA01
ATC
furosemide; systemic
1.7
10.7
322
2252
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
7.7
10.7
24
32
N02AC04
ATC
dextropropoxyphene; oral
3.3
10.7
53
167
ZXA05
NOMESCO Finland
Left side
1.7
10.6
257
1690
A02BC02
ATC
pantoprazole; systemic
1.6
10.6
596
4891
L15
ICPC
Knee symptom/complaint
1.8
10.6
200
1218
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.2
10.5
117
581
L17
ICPC
Foot/toe symptom/complaint
1.7
10.5
237
1527
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.1
10.4
123
626
35399
ICD-8 Finland
Sciatica
+∞
10.4
10
*
35700
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Nervi ulnaris
+∞
10.4
10
*
73102
ICD-8 Finland
Inflammation of the synovial membrane, bursa and tendon sheath, Tendinivaginitis stenosans
16.2
10.4
16
10
A10AE04
ATC
insulin glargine; parenteral
2.3
10.3
95
431
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
10.3
275
1857
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
10.3
69
266
J01DB01
ATC
cefalexin; oral
1.7
10.3
728
6320
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.5
10.3
81
341
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
10.2
75
304
A02BC03
ATC
lansoprazole; oral
1.7
10.2
284
1944
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
4.7
10.1
33
72
R51.80
ICD-10 Finland
Headache
2.1
10.1
125
653
N02AA05
ATC
oxycodone; systemic
1.9
10.1
160
918
R05
ICPC
Cough
1.8
9.9
198
1226
A06AD11
ATC
lactulose; oral
1.9
9.9
159
915
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
9.9
313
2209
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
16.9
9.9
15
9
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
9.9
283
1949
A10AA01
ATC
NA
5.5
9.9
28
52
A02BA02
ATC
ranitidine; systemic
1.8
9.9
205
1285
R52.2
ICD-10 Finland
Other chronic pain
3.8
9.8
40
108
J01FF01
ATC
clindamycin; systemic
1.7
9.8
235
1536
N06AX11
ATC
mirtazapine; oral
1.6
9.7
284
1962
A10AA02
ATC
NA
4.0
9.6
37
95
T89
ICPC
Diabetes insulin dependent
4.2
9.5
35
86
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.2
9.5
102
500
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.7
9.4
242
1613
9476
FHL
Splitting of fascia or aponeurosis
8.1
9.4
20
25
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.9
9.4
56
202
M03BC01
ATC
orphenadrine (citrate); systemic
1.8
9.3
186
1150
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.6
9.3
41
119
N05CF01
ATC
zopiclone; oral
1.6
9.2
306
2181
M01AB55
ATC
diclofenac, combinations; oral
2.3
9.1
82
368
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
9.1
769
6840
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
9.1
175
1069
L13
ICPC
Hip symptom/complaint
1.8
8.9
159
944
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
2.5
8.9
68
283
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
8.9
398
3040
G50.0
ICD-10 Finland
Trigeminal neuralgia
12.7
8.9
15
12
H02AB04
ATC
methylprednisolone; systemic
1.9
8.8
143
825
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
2.4
8.8
75
331
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
8.8
80
364
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
8.7
109
570
A03FA02
ATC
cisapride; oral, rectal
2.2
8.7
89
425
NC1BG
NOMESCO Finland
Elbow MRI examination with high intensity magnet
50.4
8.7
10
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
8.7
215
1415
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
8.7
219
1449
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
2.0
8.5
107
561
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
90.8
8.4
9
*
E66.9
ICD-10 Finland
Obesity, unspecified
4.1
8.4
31
77
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
8.4
169
1043
A10AE06
ATC
insulin degludec; parenteral
4.4
8.4
29
68
35708
ICD-8 Finland
Other diseases of peripheral nerves except autonomic, Alterius nervi
+∞
8.3
8
*
3542A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Lesion of ulnar nerve
+∞
8.3
8
*
73398
ICD-8 Finland
Other diseases of muscle, tendon and fascia, Alii definiti
8.6
8.3
17
20
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
8.3
117
641
A02BC01
ATC
omeprazole; systemic
1.6
8.3
259
1812
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
8.1
134
775
M77.1
ICD-10 Finland
Lateral epicondylitis
2.6
8.1
56
221
NBG10
NOMESCO Finland
Acromioplastia
3.8
8.1
33
90
X58
ICD-10 Finland
Exposure to other specified factors
1.9
8.1
114
625
H3603, E103
ICD-10 Finland
NA
11.8
8.1
14
12
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
8.1
226
1535
NBA30
NOMESCO Finland
Exploration of joint of shoulder or upper arm, arthroscopic
4.2
8.0
29
71
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
8.0
76
354
M54.3
ICD-10 Finland
Sciatica
2.6
8.0
55
216
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
8.0
52
199
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.3
8.0
38
118
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.0
7.9
45
155
T90
ICPC
Diabetes non-insulin dependent
1.6
7.9
208
1387
M79.7
ICD-10 Finland
Fibromyalgia
3.6
7.9
34
97
R60.0
ICD-10 Finland
Localized oedema
1.9
7.9
120
675
A08
ICPC
Swelling
2.8
7.9
50
186
H70
ICPC
Otitis externa
5.2
7.9
23
45
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
13.2
7.9
13
10
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.3
7.9
38
119
M02AA10
ATC
ketoprofen; topical
1.8
7.9
152
929
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
3.2
7.8
39
125
J01CA04
ATC
amoxicillin; systemic
1.5
7.8
690
6046
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
7.8
346
2620
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
7.8
90
457
L08
ICPC
Shoulder symptom/complaint
1.7
7.8
168
1059
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
7.7
109
597
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
7.7
89
450
WX320
NOMESCO Finland
Spinalanesthesy
1.6
7.7
204
1360
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
4.8
7.7
24
51
R07.3
ICD-10 Finland
Other chest pain
2.1
7.6
89
455
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
7.6
67
300
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
7.6
289
2112
M89.0
ICD-10 Finland
Algoneurodystrophy
10.1
7.5
14
14
M23.8
ICD-10 Finland
Other internal derangements of knee
3.4
7.5
35
107
A01
ICPC
Pain general/multiple sites
2.2
7.5
74
349
G47.3
ICD-10 Finland
Sleep apnoea
1.7
7.5
158
990
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
7.5
83
412
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
7.5
100
538
SPAT1260
SPAT
Consultation of another employee
1.7
7.5
164
1040
SPAT1325
SPAT
Vaccination
1.5
7.4
323
2427
K02.1
ICD-10 Finland
Caries of dentine
1.5
7.4
426
3394
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
4.6
7.4
24
53
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
5.3
7.4
21
40
E66.8
ICD-10 Finland
Other obesity
2.9
7.3
43
154
B01AB05
ATC
enoxaparin; parenteral
1.5
7.3
280
2043
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.7
7.3
47
178
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
7.3
374
2906
2505A
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI II]
+∞
7.3
7
*
9499
FHL
Other measure in this category
+∞
7.3
7
*
AA1AD
NOMESCO Finland
CT of head and brain
1.6
7.3
230
1604
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
7.2
317
2381
SPAT1301
SPAT
No procedures
1.5
7.2
284
2085
P01AB01
ATC
metronidazole; oral, rectal
1.5
7.2
339
2591
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.0
7.2
85
435
M47.9
ICD-10 Finland
Spondylosis, unspecified
3.3
7.2
34
106
NDF25
NOMESCO Finland
Operation for osteochondritis of joint of wrist, arthroscopic
20.2
7.1
10
5
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
4.1
7.1
26
65
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
4.6
7.1
23
51
A02BC05
ATC
esomeprazole; systemic
1.5
7.1
359
2777
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
5.4
7.1
20
38
M79.1
ICD-10 Finland
Myalgia
1.9
7.1
106
593
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.4
7.1
32
96
L28
ICPC
Limited function/disability (L)
1.7
7.1
166
1070
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
3.7
7.0
29
81
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.0
548
4621
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.0
177
1168
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.8
6.9
114
660
M01AX05
ATC
glucosamine; oral
1.6
6.9
216
1501
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.8
6.9
42
156
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
6.8
212
1469
R03DC03
ATC
montelukast; oral
1.7
6.8
136
834
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.8
113
658
7263A
ICD-9 Finland
Peripheral enthesopathies and allied syndromes, Enthesopathy of elbow region[EPICONDYLITIS LATERALIS HUMERI]
9.4
6.8
13
14
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
40.3
6.8
8
*
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
40.3
6.8
8
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.8
218
1527
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
4.1
6.7
24
59
G56.9
ICD-10 Finland
Mononeuropathy of upper limb, unspecified
22.7
6.7
9
*
J01FA10
ATC
azithromycin; systemic
1.4
6.7
450
3674
A10BA02
ATC
metformin; oral
1.5
6.6
248
1792
TQW40
SPAT
NA
3.4
6.6
29
86
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
4.0
6.5
24
61
7170A
ICD-9 Finland
Internal derangement of knee, Old bucket handle tear of medial meniscus
3.7
6.5
26
71
R42
ICD-10 Finland
Dizziness and giddiness
1.5
6.5
215
1513
6451
FHL
Dilatation
5.7
6.5
17
30
M67.4
ICD-10 Finland
Ganglion
2.4
6.5
53
232
TAB20
NOMESCO Finland
Epidural puncture
8.2
6.3
13
16
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
2.5
6.3
46
189
L14
ICPC
Leg/thigh symptom/complaint
2.1
6.3
71
358
M09AX01
ATC
hyaluronic acid; parenteral
2.2
6.3
59
274
S97
ICPC
Chronic ulcer skin
2.3
6.3
54
241
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
6.3
477
3965
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
6.3
244
1779
3548X
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Other mononeuritis of upper limb
+∞
6.3
6
*
S64.1
ICD-10 Finland
Injury of median nerve at wrist and hand level
+∞
6.3
6
*
G58.7
ICD-10 Finland
Mononeuritis multiplex
+∞
6.3
6
*
3543A
ICD-9 Finland
Mononeuritis of upper limb and mononeuritis multiplex, Lesion of radial nerve
+∞
6.3
6
*
M18.0
ICD-10 Finland
Primary arthrosis of first carpometacarpal joints, bilateral
4.8
6.2
19
40
J01FA06
ATC
roxithromycin; oral
1.4
6.2
345
2703
7270B
ICD-9 Finland
Other disorders of synovium, tendon and bursa, Synovitis and tenosynovitis[TENOSYNOVITIS CARPI ET ANTEBRACHII]
26.9
6.2
8
*
160
Kela drug reimbursment
exenatide
4.0
6.2
23
59
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.5
6.2
20
45
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
6.2
138
876
J01MA02
ATC
ciprofloxacin; systemic
1.4
6.2
328
2548
R13
ICD-10 Finland
Dysphagia
2.2
6.2
60
282
M54.1
ICD-10 Finland
Radiculopathy
2.8
6.1
37
137
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
12.6
6.1
10
8
9481
FHL
Detachment or severance of a muscle or tendon
8.7
6.1
12
14
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
2.2
6.0
55
253
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.6
6.0
41
163

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
519
3801
1.73
16.53
4.1
3.9
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
375
2602
1.69
13.88
2.2
2.1
u/l
152.6
223.8
1.58
351
2435
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
454
3377
1.61
12.41
4.4
3.8
ng/l
40.1
49.6
0.35
350
2458
(3013707) Erythrocyte sedimentation rate by Westergren method
735
6149
1.67
12.35
5.1
4.0
mm/h
13.6
13.7
0.07
679
5579
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
556
4394
1.57
11.39
7.3
6.2
mmol/l
1.2
1.2
0.01
479
3646
(3013826) Glucose [Moles/volume] in Serum or Plasma
612
4982
1.56
10.71
5.0
4.5
mmol/l
7.3
6.7
4.54
587
4648
(3024561) Albumin [Mass/volume] in Serum or Plasma
491
3823
1.54
10.40
4.9
4.4
g/l
34.8
35.0
0.36
444
3533
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
359
2607
1.58
10.38
2.4
2.4
u/l
51.6
57.7
3.53
330
2365
(3026493) Urate [Moles/volume] in Serum or Plasma
298
2080
1.61
10.16
2.7
2.6
umol/l
358.0
8897.9
9.50
249
1776
(3012516) Albumin [Mass/volume] in Urine
340
2454
1.57
10.03
3.4
3.1
mg/l
299.9
240.8
0.10
211
1484
(3009508) Creatinine [Moles/volume] in Urine
349
2543
1.56
9.83
3.3
3.0
mmol/l
6.9
6.9
0.04
290
2093
(3007853) Bacteria identified in Skin by Aerobe culture
158
937
1.81
9.83
2.0
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
761
6580
1.59
9.64
7.5
7.2
u/l
77.2
79.7
1.19
715
6100
(3032080) INR in Blood by Coagulation assay
459
3568
1.51
9.52
9.3
9.8
inr
1.3
1.3
0.17
109
1007
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
505
4024
1.50
9.19
6.6
5.5
mmol/l
1.2
1.2
0.16
455
3563
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
288
2041
1.57
9.04
2.2
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
182
1154
1.70
8.93
2.1
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
358
2671
1.52
8.86
2.3
2.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
352
2623
1.52
8.74
4.2
3.8
mg/mmol
14.4
8.1
0.83
214
1571
(3031040) Bacteria [#/volume] in Urine by Automated count
671
5697
1.50
8.73
5.5
4.9
e6/l
2160.8
1972.5
0.03
12
100
(3013115) Eosinophils [#/volume] in Blood
513
4153
1.47
8.31
6.0
5.6
e9/l
0.2
0.2
1.08
462
3599
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
370
2829
1.48
7.94
3.2
3.0
ng/l
1687.6
1520.3
0.30
314
2416
(3037467) Urinalysis macro (dipstick) panel - Urine
678
5823
1.48
7.91
5.4
4.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
93
499
1.95
7.87
3.8
3.4
mmol/l
1.4
2.0
0.74
75
378
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
97
529
1.92
7.82
3.7
3.4
kpa
5.3
5.2
0.79
91
485
(3009343) pH of Capillary blood
96
522
1.92
7.81
3.8
3.4
ph
7.4
7.4
—
8
63
(3023368) Bacteria identified in Blood by Culture
319
2379
1.49
7.70
4.4
4.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
191
1272
1.61
7.67
1.3
1.2
iu/ml
27.5
34.4
0.42
61
414
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
184
1219
1.62
7.54
1.3
1.2
u/ml
17.2
13.5
0.26
65
451
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
731
6399
1.48
7.53
4.4
4.0
pmol/l
15.0
15.0
0.05
653
5711
(3013650) Neutrophils [#/volume] in Blood by Automated count
569
4766
1.43
7.30
8.0
8.6
e9/l
4.3
4.2
0.91
499
4147
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
446
3576
1.43
7.29
2.4
2.2
nmol/l
79.5
78.6
0.26
381
3120
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
896
8221
1.67
7.25
19.4
14.7
mg/l
23.4
24.8
0.62
763
6552
(3006315) Basophils [#/volume] in Blood
490
4012
1.42
7.05
6.0
5.4
e9/l
0.0
0.0
0.82
433
3436
(3001604) Monocytes [#/volume] in Blood
488
3998
1.42
6.97
5.9
5.4
e9/l
0.6
0.6
0.98
431
3416
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
302
2269
1.47
6.90
2.5
2.1
mg/l
3.1
3.1
0.14
262
1897
(3019150) Specific gravity of Urine by Refractometry
247
1798
1.49
6.57
5.3
4.5
kg/l
1.0
1.0
0.27
41
263
(3015377) Calcium [Moles/volume] in Serum or Plasma
392
3126
1.41
6.37
2.7
3.4
mmol/l
2.4
2.4
0.15
324
2657
(42870588) Differential panel, method unspecified - Blood
348
2720
1.42
6.33
6.2
5.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
145
947
1.62
6.26
1.3
1.3
titre
432.5
595.4
0.97
32
199
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
455
3735
1.39
6.18
2.3
2.0
pmol/l
90.4
94.4
0.84
201
1816
(3019198) Lymphocytes [#/volume] in Blood
493
4101
1.39
6.18
5.9
5.4
e9/l
1.9
1.9
0.18
446
3575
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
52
250
2.14
5.97
2.0
2.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
188
1319
1.52
5.93
2.2
1.9
s
29.8
29.7
0.05
183
1274
(1761868) Lipid panel - Serum or Plasma
192
2623
0.67
5.78
3.1
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
238
1760
1.46
5.77
1.6
1.6
mg/l
1.1
1.2
0.21
187
1357
(3022313) Gas panel - Capillary blood
71
388
1.89
5.73
3.7
3.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
524
4453
1.36
5.52
5.2
6.0
umol/l
10.5
11.7
2.79
496
4196
(3037121) Protein [Mass/volume] in Urine
55
279
2.03
5.51
3.2
3.1
g/l
0.2
0.2
0.02
18
105
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
79
459
1.78
5.26
2.8
3.0
pmol/l
4.2
4.5
1.12
67
389
(3006504) Eosinophils/100 leukocytes in Blood
451
3766
1.35
5.23
6.1
5.6
%
2.8
2.7
0.34
417
3476
(3019069) Monocytes/100 leukocytes in Blood
452
3784
1.35
5.12
6.4
5.9
%
8.7
8.7
0.11
418
3507
(3022096) Basophils/100 leukocytes in Blood
439
3661
1.35
5.10
6.2
5.7
%
0.6
0.7
0.48
407
3379
(3035350) Ketones [Presence] in Urine by Test strip
484
4096
1.34
5.09
4.5
4.0
estimate
0.0
0.0
0.00
91
760
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
111
715
1.62
5.07
4.4
3.2
ng/l
104.9
88.7
0.84
88
597
(3004588) Protein electrophoresis panel - Serum or Plasma
96
598
1.67
5.00
1.6
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
112
726
1.61
4.98
8.5
6.1
mmol/l
12.8
10.2
1.84
102
682
(3018418) pH of Serum or Plasma
329
2636
1.36
4.92
4.7
3.8
ph
7.4
7.4
0.91
60
500
(3003458) Phosphate [Moles/volume] in Serum or Plasma
157
1103
1.50
4.88
7.2
4.8
mmol/l
1.1
1.0
1.64
143
986
(4146454)
23
84
2.78
4.80
3.2
2.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
141
977
1.51
4.68
6.2
7.1
mmol/l
0.8
1.2
0.43
107
766
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
224
1700
1.41
4.62
4.1
3.8
ng/l
211.1
346.0
0.78
182
1393
(3018010) Neutrophils/100 leukocytes in Blood
450
3805
1.32
4.62
6.0
5.5
%
58.4
58.1
0.23
414
3522
(3016502) Oxygen saturation in Arterial blood
126
855
1.54
4.61
6.0
7.5
%
95.9
95.7
0.18
119
822
(3015736) pH of Urine
385
3185
1.33
4.60
4.2
3.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
155
1101
1.48
4.56
7.5
7.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
140
974
1.51
4.56
6.2
7.1
kpa
5.1
5.1
0.26
132
922
(3027801) Oxygen [Partial pressure] in Arterial blood
140
974
1.51
4.56
6.2
7.1
kpa
12.6
11.9
0.72
131
925
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
63
362
1.79
4.39
1.7
2.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
274
2167
1.36
4.38
1.6
1.5
nmol/l
19.7
20.9
0.59
224
1784
(3020630) Protein [Mass/volume] in Serum or Plasma
106
700
1.57
4.38
2.1
2.6
g/l
65.1
66.3
0.98
89
630
(3002030) Lymphocytes/100 leukocytes in Blood
454
3866
1.31
4.35
6.3
5.8
%
26.5
26.9
0.28
418
3560
(3019550) Sodium [Moles/volume] in Serum or Plasma
913
8622
1.50
4.25
22.7
17.5
mmol/l
139.5
139.6
0.80
888
8355
(3000475) Leukocytes [#/volume] in Synovial fluid
38
186
2.08
4.24
1.4
1.5
e6/l
24790.9
16195.1
0.30
26
133
(3009261) Glucose [Presence] in Urine by Test strip
483
4174
1.29
4.05
4.5
4.0
estimate
0.0
0.0
0.50
88
749
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
823
7651
1.37
4.00
5.5
4.9
mu/l
1.9
2.1
0.90
741
6873
(3021601) Nitrite [Presence] in Urine by Test strip
478
4136
1.29
3.93
5.9
5.4
estimate
0.0
0.0
0.00
92
747
(3022217) INR in Platelet poor plasma by Coagulation assay
167
1239
1.41
3.90
23.9
28.4
inr
1.3
1.4
0.42
21
152
(3019309) Folate [Moles/volume] in Red Blood Cells
234
1838
1.35
3.86
1.9
1.8
nmol/l
1113.0
1225.2
1.00
174
1335
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
46
250
1.88
3.85
1.3
1.5
—
163.3
—
0
12
(3023103) Potassium [Moles/volume] in Serum or Plasma
912
8642
1.46
3.84
23.2
17.6
mmol/l
4.0
4.0
3.88
886
8365
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
197
1507
1.38
3.84
1.8
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
571
5064
1.28
3.83
3.4
3.0
u/l
46.4
49.9
0.53
524
4594
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
41
215
1.94
3.82
1.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
275
2217
1.33
3.81
4.8
4.4
estimate
0.0
0.0
0.50
92
730
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
371
3127
1.29
3.68
3.5
3.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
212
1652
1.36
3.67
1.2
1.2
u/ml
1.8
1.7
0.04
54
430
(3044927) Protein electrophoresis panel - Urine
22
91
2.45
3.65
1.3
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
69
432
1.64
3.58
7.9
3.1
mmol/l
23.8
24.1
0.21
59
396
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
39
206
1.93
3.57
1.5
2.5
g/l
4.2
3.5
1.42
39
199
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
30
144
2.12
3.56
1.0
1.2
u/ml
2.3
1.9
—
5
14
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
56
334
1.72
3.49
1.6
1.9
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
114
805
1.47
3.47
2.4
2.4
ug/l
5.1
7.5
1.62
88
683
(3004789) Transferrin [Mass/volume] in Serum or Plasma
159
1194
1.39
3.46
3.3
2.3
g/l
2.4
2.3
0.39
132
1093
(3011397) Hemoglobin [Presence] in Urine by Test strip
245
1968
1.32
3.44
4.5
3.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
823
7703
1.33
3.43
7.3
5.9
mmol/mol
42.1
40.1
6.30
738
7016
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
240
1.83
3.35
1.4
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
154
1157
1.39
3.34
1.3
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
17
65
2.64
3.31
1.4
1.3
e6/l
43385.3
150607.7
—
10
48
(3027945) Reticulocytes/100 erythrocytes in Blood
138
1019
1.41
3.31
2.3
2.3
%
1.8
1.9
0.85
111
890
(3018095) Leukocytes [#/volume] in Urine
362
3087
1.27
3.17
3.9
3.7
e6/l
99.1
120.6
0.19
270
2210
(3007164) IgA [Mass/volume] in Serum or Plasma
184
1435
1.34
3.16
1.4
1.4
g/l
2.5
2.5
0.06
109
835
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
113
812
1.44
3.16
3.5
2.9
ng/l
213.4
253.3
0.42
101
747
(3022948) Iron [Moles/volume] in Serum or Plasma
170
1314
1.35
3.09
3.3
2.3
umol/l
11.2
12.5
1.89
148
1204
(3000850) Epithelial cells [#/volume] in Urine
231
1869
1.30
3.06
2.5
2.6
e6/l
6.0
6.3
0.12
205
1648
(3019225) pH of Specimen
123
903
1.41
3.06
5.2
3.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
357
3052
1.26
3.04
3.5
3.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
148
1126
1.37
2.98
3.4
2.4
%
19.9
21.8
0.89
118
955
(3017732) Neutrophils [#/volume] in Blood
76
512
1.52
2.93
2.6
3.3
e9/l
4.2
4.1
0.17
50
374
(3033658) Prothrombin time (PT) actual/Normal
258
2135
1.28
2.86
3.8
3.7
%
90.3
88.7
0.45
250
2078
(3044941) Cell count panel - Synovial fluid
25
123
2.06
2.83
1.3
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
170
1333
1.33
2.81
3.0
3.1
mmol/l
0.8
0.8
0.38
162
1232
(40761535) Cells panel - Urine sediment
100
719
1.43
2.80
3.8
3.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
109
797
1.41
2.78
6.3
7.9
g/l
120.1
119.4
0.12
101
768
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
66
439
1.54
2.72
7.0
9.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
141
1081
1.35
2.71
4.7
4.5
%
32.4
33.2
0.34
85
670
(3001122) Ferritin [Mass/volume] in Serum or Plasma
394
3443
1.23
2.69
3.4
2.7
ug/l
116.1
129.6
0.71
350
3101
(4010399)
81
566
1.47
2.64
1.4
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
121
909
1.37
2.64
2.1
2.6
umol/l
6.2
9.4
1.46
111
789
(3016018) Differential panel - Cerebral spinal fluid
16
67
2.41
2.64
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
40
237
1.72
2.61
1.9
1.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
79
552
1.47
2.59
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
94
2.15
2.56
1.4
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
76
530
1.47
2.52
8.1
7.4
mmol/l
24.3
24.5
0.17
68
493
(3019060) Gas panel - Arterial blood
80
564
1.45
2.51
5.5
5.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
21
3.83
2.46
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
13
51
2.57
2.45
1.1
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
13
51
2.57
2.45
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
38
227
1.70
2.43
1.8
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
308
2646
1.23
2.42
3.4
3.2
e6/l
23.4
87.2
1.71
254
2045
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
68
468
1.48
2.41
2.7
2.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
90
2.13
2.40
2.1
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
27
146
1.87
2.39
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
102
760
1.38
2.36
2.1
2.4
e9/l
67.8
71.9
0.61
73
584
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
170
1.79
2.30
1.1
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
18
85
2.14
2.29
1.3
1.4
%
56.9
63.4
—
9
57
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
86
626
1.41
2.29
1.5
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
23
3.50
2.27
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
488
4411
1.20
2.26
2.7
2.6
—
—
—
0
0
(3013512) EKG study
304
2627
1.22
2.24
4.8
4.0
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
53
352
1.53
2.24
1.7
1.9
ug/l
1.4
2.3
0.36
44
304
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
359
3155
1.21
2.23
5.0
4.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
32
187
1.73
2.23
1.1
1.2
u/ml
13.4
2.3
—
8
20
(3000494) Fungus identified in Specimen by Culture
121
936
1.33
2.21
1.3
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
32
188
1.72
2.19
1.1
1.2
u/ml
5.4
3.6
—
8
34
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
606
1.40
2.18
1.7
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
18
87
2.09
2.18
1.1
1.2
u/l
75.1
50.1
0.72
12
60
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
251
1.62
2.15
1.5
1.4
ug/g
252.6
283.3
0.36
20
138
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
27
152
1.80
2.13
1.6
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
325
1.53
2.10
1.2
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
325
1.53
2.10
1.2
2.2
g/l
7.8
7.5
0.39
35
233
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
325
1.53
2.10
1.2
2.2
g/l
3.5
3.8
0.99
33
226
(3045788) Cell count panel - Pleural fluid
18
89
2.04
2.06
1.7
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
45
295
1.55
2.03
1.2
2.3
g/l
3.1
3.2
0.33
34
231
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
50
2.42
2.03
1.6
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
25
140
1.81
2.02
1.3
1.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
10
38
2.65
2.01
1.7
1.4
promille
0.8
1.1
—
10
28
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
210
1.64
1.97
1.7
1.6
iu/ml
0.2
0.1
—
10
43
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
51
2.37
1.95
1.7
1.6
u/l
5.9
6.6
—
7
29
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
282
1.55
1.95
1.9
3.5
mg/l
33.8
53.1
0.81
38
224
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
282
1.55
1.95
1.9
3.5
mg/l
59.1
74.3
0.22
38
224
(3000991) Gas panel - Venous blood
94
715
1.35
1.95
7.1
6.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
290
2526
1.21
1.94
3.5
3.1
u/l
28.4
34.6
3.39
272
2378
(3025549) Creatine [Moles/time] in 24 hour Urine
5
11
4.56
1.94
1.4
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
33
2.74
1.93
3.4
2.6
u/ml
3381.0
1438.1
—
9
33
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
907
8761
1.28
1.91
12.3
10.4
u/l
24.4
24.4
0.01
868
8368
(3045414) Leukocytes [Presence] in Urine
52
359
1.47
1.87
2.1
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
42
277
1.54
1.87
1.9
3.4
ratio
1.5
1.9
—
7
23
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
27
159
1.72
1.86
1.0
1.3
e6/l
204.7
201.4
0.01
19
128
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
27
159
1.72
1.86
1.0
1.2
e6/l
42.2
7.6
0.40
16
121
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
132
1060
1.28
1.86
1.7
1.7
—
—
—
0
0
(4062490)
13
59
2.22
1.84
1.1
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
6
17
3.54
1.84
1.2
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
227
1941
1.22
1.83
1.8
1.7
pmol/l
91489821.5
16451211.9
0.57
188
1544
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.18
1.82
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
108
848
1.31
1.81
4.5
3.2
mmol/l
1.8
1.9
0.01
87
687
(3045424) Erythrocytes [Presence] in Urine
22
123
1.81
1.81
1.1
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
176
1.67
1.81
1.0
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
882
8505
1.25
1.79
19.1
14.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
214
1825
1.22
1.78
2.7
3.0
mmol/l
2.4
2.5
1.62
181
1622
(3002179) Metamyelocytes/100 leukocytes in Blood
84
638
1.34
1.77
3.2
4.0
%
0.5
0.5
0.04
19
140
(3017181) Myelocytes/100 leukocytes in Blood
92
709
1.33
1.76
3.5
4.1
%
0.6
0.9
0.97
27
198
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
67
2.10
1.76
1.3
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
87
667
1.33
1.73
3.6
4.2
%
0.1
0.1
0.10
24
176
(3010813) Leukocytes [#/volume] in Blood
935
9086
1.30
1.73
28.3
21.8
e9/l
7.1
6.7
1.88
900
8763
(3048689) Calprotectin [Mass/mass] in Stool
109
865
1.29
1.70
1.8
2.1
ug/g
161.2
135.1
0.50
74
666
(3024928) Oxygen saturation in Venous blood
32
204
1.59
1.67
3.1
2.3
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
69
2.04
1.65
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
113
905
1.28
1.65
1.3
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
189
1.60
1.64
2.1
2.2
ug/min
93.6
67.5
0.17
14
118
(3023323) Follitropin [Units/volume] in Serum or Plasma
32
205
1.58
1.64
1.3
1.3
iu/l
38.7
30.7
0.54
26
177
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
12
56
2.16
1.61
1.0
1.1
—
—
—
0
0
(4027681)
8
32
2.51
1.60
1.1
1.2
—
—
—
0
0
(4024509)
15
77
1.96
1.59
1.5
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
41
280
1.48
1.59
1.2
1.2
u/ml
0.7
1.6
—
5
19
(3007461) Platelets [#/volume] in Blood
933
9080
1.28
1.58
28.3
21.8
e9/l
250.8
249.6
0.23
904
8792
(3035880) pH of Pleural fluid
11
50
2.21
1.57
1.8
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
11
50
2.21
1.57
3.3
1.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
933
9082
1.27
1.56
28.1
21.7
fl
91.4
91.4
0.00
912
8901
(3000492) Spirometry study
87
679
1.31
1.55
1.5
1.5
—
—
—
0
0
(3035941) MCH [Entitic mass]
933
9083
1.27
1.55
28.1
21.7
pg
30.3
30.3
0.19
912
8900
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
282
1.47
1.54
2.3
2.4
u/ml
0.4
0.3
0.36
22
164
(3026361) Erythrocytes [#/volume] in Blood
933
9084
1.27
1.54
28.2
21.8
e12/l
4.4
4.4
1.29
897
8765
(4133840)
5
15
3.34
1.52
1.6
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
93
1.84
1.52
1.8
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
129
1061
1.25
1.52
1.7
1.7
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
933
9087
1.27
1.51
28.5
21.9
g/l
131.7
132.8
1.56
913
8907
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
532
1.34
1.50
1.5
1.5
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
58
2.08
1.49
1.1
1.3
g/l
6.7
7.3
—
5
39
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
58
2.08
1.49
1.1
1.3
g/l
0.3
0.4
—
5
39
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
310
1.44
1.47
1.2
2.2
g/l
9.1
10.3
1.21
38
259
(36304419) Bacteria [Presence] in Urine
267
2364
1.17
1.46
3.3
3.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
828
7976
1.19
1.46
4.8
4.4
mmol/l
1.4
1.5
3.03
745
7167
(3017143) Hepatitis C virus Ab [Presence] in Serum
86
677
1.29
1.45
1.8
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
115
939
1.25
1.45
1.8
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
22
2.74
1.43
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
141
1.65
1.42
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
628
5929
1.15
1.42
4.3
3.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
80
626
1.30
1.42
3.3
4.2
%
0.0
0.1
1.15
21
149
(40758558) Short blood count panel - Blood
241
2123
1.18
1.40
5.7
6.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
40
2.26
1.40
1.4
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
854
8257
1.20
1.40
5.4
5.0
mmol/l
2.6
2.7
3.67
768
7428
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
60
2.01
1.38
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
28
183
1.54
1.35
2.2
2.1
g/l
125.7
127.0
0.11
19
138
(4034850)
39
275
1.43
1.32
10.9
10.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
41
0.00
1.31
0.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
30
201
1.51
1.31
1.8
1.6
iu/l
2.5
5.0
1.90
12
65
(40768443) Skin Pathology biopsy report
52
387
1.36
1.30
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
24
2.51
1.30
1.0
1.0
miu/ml
1568.5
1770.0
—
6
24
(40760888) Immunoglobulin light chains.free panel - Serum
30
202
1.50
1.28
2.1
3.9
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
83
663
1.27
1.28
2.4
2.8
ml/min/173m2
58.0
62.2
0.67
32
289
(3051593) INR in Capillary blood by Coagulation assay
9
44
2.05
1.27
12.0
13.6
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
18
107
1.69
1.26
1.6
1.4
e6/l
1920.3
1350.6
0.41
12
76
(3036489) Thrombin time
39
278
1.42
1.26
1.6
1.9
s
21.0
21.2
0.11
34
246
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
39
279
1.41
1.24
1.2
2.5
g/l
0.0
1.0
3.31
33
231
(3004616) Nuclear Ab [Presence] in Serum
15
85
1.78
1.23
1.1
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
37
263
1.42
1.22
1.2
2.2
g/l
38.4
37.1
0.56
30
217
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
15
251
0.59
1.21
2.0
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
42
306
1.39
1.21
3.4
2.1
u/l
36.5
40.0
0.53
36
266
(3024354) Oxygen [Partial pressure] in Venous blood
89
723
1.25
1.20
3.2
2.5
kpa
4.7
4.5
0.26
84
697
(3003694) ABO and Rh group [Type] in Blood
232
2064
1.16
1.19
1.3
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
38
2.11
1.18
1.3
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
202
1780
1.17
1.17
2.8
2.8
mosm/kgh2o
529.3
537.8
0.23
178
1509
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
832
8059
1.16
1.17
4.9
4.4
mmol/l
4.5
4.7
2.71
756
7289
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
110
1.65
1.16
2.2
1.8
pmol/l
177.3
211.8
0.88
18
104
(3030467) Casts [#/volume] in Urine by Automated count
271
2445
1.15
1.15
3.3
3.1
e6/l
0.3
0.5
1.23
215
1858
(3047181) Lactate [Moles/volume] in Blood
36
259
1.40
1.13
7.1
7.7
mmol/l
1.6
1.3
0.69
30
226
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
836
8108
1.16
1.12
5.4
4.7
mmol/l
6.3
6.0
5.43
748
7214
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
40
2.01
1.12
1.0
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
16
96
1.68
1.10
1.6
1.4
e6/l
48071.8
98110.7
—
8
54
(3040151) Glucose [Moles/volume] in Capillary blood
15
89
1.70
1.08
8.2
5.5
mmol/l
7.8
7.7
—
10
74
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
40
532
0.74
1.06
1.6
1.8
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
97
810
1.22
1.04
2.6
2.2
u/l
27.2
37.8
2.30
88
684
(4306422)
16
98
1.64
1.03
1.3
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
17
106
1.61
1.03
1.2
1.2
u/ml
1.6
8.0
—
5
44
(3000012) Reticulocyte production index
9
47
1.92
1.02
2.0
1.8
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
12
68
1.77
1.00
2.1
2.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
808
7838
1.14
0.99
16.7
14.1
ml/min/173m2
74.3
76.2
1.40
702
6413
(1616796) Gas panel - Central venous blood
26
181
1.45
0.99
3.8
3.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
87
724
1.22
0.98
1.6
2.1
nmol/l
367.7
389.3
0.48
76
652
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
100
1.61
0.97
1.3
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
50
1.81
0.96
1.3
1.1
—
102.5
—
0
8
(4268621)
12
69
1.75
0.96
2.3
2.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
796
7721
1.13
0.95
4.3
3.9
mmol/l
1.4
1.3
5.06
712
6873
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
77
1.70
0.95
5.2
3.6
%
66.8
54.0
—
8
52
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
32
0.00
0.95
0.0
1.4
—
—
—
0
0
(4211845)
7
37
1.90
0.94
1.6
4.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
89
746
1.21
0.94
5.0
3.6
mmol/l
1.2
1.2
0.47
76
632
(3033799) Differential panel - Peritoneal fluid
6
27
2.23
0.93
1.0
1.8
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
6
27
2.23
0.93
4.8
1.9
ug/l
29.6
337.0
—
6
22
(3022621) pH of Urine by Test strip
71
582
1.24
0.93
3.7
3.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
238
2160
1.13
0.92
1.7
1.6
mmol/l
1.6
1.4
1.32
203
1783
(3005719) IgG [Mass/volume] in Serum or Plasma
69
564
1.24
0.92
2.6
2.9
g/l
10.4
10.6
0.15
61
509
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
55
1.83
0.92
2.6
2.4
—
—
—
0
0
(3020891) Body temperature
44
340
1.31
0.92
4.3
4.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
19
127
1.51
0.89
1.6
6.9
iu/ml
—
167.5
—
0
20
(3021901) Oxygen saturation in Capillary blood
22
152
1.46
0.88
3.3
2.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
15
95
1.59
0.87
2.0
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
191
1716
1.14
0.87
4.0
4.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
30
2.01
0.87
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
195
1.39
0.87
1.5
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
18
120
1.51
0.85
2.1
2.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
88
1.60
0.84
2.3
3.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
56
454
1.25
0.82
1.7
1.7
g/l
1.3
1.4
0.34
51
407
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
25
180
1.40
0.82
1.8
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
34
258
1.33
0.82
3.6
3.5
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
8
47
1.71
0.80
1.1
1.7
umol/l
12.8
12.3
—
8
42
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
114
1.50
0.79
1.7
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
6
33
1.82
0.79
1.7
4.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
131
1.46
0.78
1.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
90
1.56
0.78
2.4
4.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
93
800
1.18
0.77
1.9
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
107
932
1.17
0.76
3.4
3.8
u/l
241.1
248.7
0.32
95
880
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
92
792
1.18
0.76
1.7
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
357
3350
1.10
0.76
2.2
2.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
59
1.70
0.76
1.2
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
53
1.70
0.75
1.4
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
22
301
0.73
0.75
1.5
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
60
1.67
0.72
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
60
1.67
0.72
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
60
1.67
0.72
1.2
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
215
1972
1.11
0.71
4.8
4.9
ug/l
2.0
3.1
1.75
198
1755
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
23
169
1.37
0.70
1.1
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
61
1.65
0.68
1.0
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
1.6
2.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
15
102
1.48
0.67
1.2
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
92
0.54
0.67
2.4
2.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
95
0.52
0.66
1.4
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
163
1479
1.12
0.66
2.9
2.7
e6/l
1.1
1.5
0.57
94
842
(3041096) Erythrocytes [Presence] in Urine by Automated
236
2186
1.10
0.65
4.0
3.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
53
441
1.21
0.65
2.8
2.2
%
0.6
0.6
0.69
48
425
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
29
1.73
0.64
1.2
1.4
pmol/l
15.2
14.5
—
5
21
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
16
112
1.44
0.63
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
16
112
1.44
0.63
1.4
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
92
808
1.15
0.62
1.8
2.1
g/l
0.2
0.2
0.78
85
749
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
63
1.59
0.62
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
2.2
2.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
16
113
1.42
0.61
1.4
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
13
88
1.48
0.60
1.3
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
445
1.20
0.60
1.3
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
97
1.45
0.59
2.9
3.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
108
964
1.13
0.58
2.7
4.2
ug/l
21.5
26.8
0.11
84
795
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
113
0.62
0.58
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
149
1.35
0.58
5.9
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
115
1.40
0.56
1.4
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
11
73
1.51
0.56
1.1
1.0
u/ml
4.5
4.2
—
5
31
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
29
361
0.80
0.54
1.3
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
116
1.39
0.54
1.4
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
82
1.47
0.54
1.2
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
126
0.63
0.54
1.1
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
38
1.58
0.54
3.7
6.2
u/ml
—
96.4
—
0
10
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
38
1.58
0.54
1.0
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
24
187
1.29
0.53
4.3
4.1
mmol/l
2.3
2.9
0.47
19
126
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
3.5
6.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
39
1.54
0.53
1.8
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
39
1.54
0.53
1.8
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
66
1.52
0.52
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
100
0.60
0.52
1.2
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
48
408
1.19
0.50
1.5
1.6
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
10
67
1.50
0.49
1.6
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
62
709
0.87
0.49
4.6
4.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
44
515
0.85
0.47
1.4
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
7
48
1.46
0.47
1.3
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
120
1.34
0.46
1.1
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
18
138
1.31
0.45
1.7
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
85
0.59
0.45
1.6
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
25
201
1.25
0.45
1.6
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
150
1389
1.09
0.44
3.1
2.9
e6/l
5.9
3.2
1.26
84
756
(44790047)
11
78
1.41
0.43
1.0
1.5
—
—
—
0
0
(44806118)
11
78
1.41
0.43
1.0
1.5
—
—
—
0
0
(44790049)
11
78
1.41
0.43
1.0
1.5
—
—
—
0
0
(44790048)
11
78
1.41
0.43
1.0
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
31
1.62
0.43
1.2
1.4
—
—
—
0
0
(4094501)
17
218
0.78
0.43
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
57
1.41
0.42
1.1
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
149
1.28
0.42
1.6
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
96
1.36
0.41
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
8
58
1.38
0.41
3.1
3.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
433
0.85
0.41
1.6
1.8
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
17
0.00
0.40
0.0
5.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
16
123
1.31
0.40
3.6
2.5
mg/l
48.4
29.5
—
5
31
(3028300) Cannabinoids [Presence] in Urine
19
150
1.27
0.40
1.7
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
150
1.27
0.40
1.6
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
103
0.68
0.39
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
97
1.34
0.39
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
22
178
1.24
0.39
1.4
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
25
206
1.22
0.38
3.0
2.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
24
197
1.22
0.38
1.3
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
116
1072
1.09
0.37
1.4
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
116
1.30
0.37
1.5
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
134
1.27
0.37
1.1
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
72
1.39
0.37
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
72
1.39
0.37
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
267
0.82
0.36
5.8
5.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
135
0.74
0.36
3.3
2.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
53
471
1.13
0.35
1.3
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
190
1.22
0.35
1.1
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
91
1.32
0.34
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
110
1021
1.09
0.33
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
6
89
0.67
0.33
1.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
47
1.28
0.32
1.8
3.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
83
1.33
0.32
1.3
1.1
u/ml
1.5
1.6
—
6
30
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
14
110
1.28
0.31
1.1
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
13
101
1.29
0.31
1.2
1.8
g/l
0.4
0.9
—
7
78
(1002224) Polysomnography panel
21
251
0.83
0.31
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
7
53
1.32
0.31
1.7
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
7
54
1.30
0.30
1.7
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
55
1.27
0.30
3.9
2.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
44
493
0.89
0.30
4.2
3.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
8
109
0.73
0.29
1.5
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
7
57
1.23
0.29
1.6
1.2
u/ml
0.0
0.9
—
7
27
(3027944) Amphetamines [Presence] in Urine
18
149
1.21
0.28
1.5
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
64
1.25
0.27
1.8
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
79
731
1.09
0.27
2.0
1.8
%
1.4
1.5
0.28
70
632
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
43
385
1.12
0.27
2.1
1.7
g/l
1.6
1.6
0.10
35
332
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
25
215
1.17
0.27
2.0
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
165
1573
1.06
0.26
4.0
4.3
%
25.0
21.6
1.47
73
757
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
105
1.24
0.25
1.1
1.7
—
—
—
0
0
(4035726)
70
755
0.92
0.24
1.4
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
83
0.72
0.24
1.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
84
0.71
0.24
1.0
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.2
1.9
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
232
0.86
0.23
1.6
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
39
1.28
0.23
1.6
3.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
32
358
0.89
0.22
3.2
3.2
u/ml
5531.4
8362.0
0.12
26
307
(3008295) Osmolality of Serum or Plasma
11
88
1.25
0.22
1.9
1.4
mosm/kgh2o
271.8
273.2
—
6
63
(3047189) Immunofixation for 24 hour Urine
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
20
172
1.17
0.22
1.4
1.3
mmol/l
56.2
58.9
0.13
14
135
(3004451) EKG impression Narrative
5
41
1.22
0.22
1.4
1.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
41
1.22
0.22
1.8
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
41
1.22
0.22
1.8
1.4
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
176.0
—
0
5
(3036048) Francisella tularensis Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.5
—
54.9
—
0
10
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
12
0.00
0.21
0.0
3.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.9
—
18.0
—
0
13
(40758292) HTLV I+II Ab panel - Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
49.7
—
0
6
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
108
1.21
0.20
1.2
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
56
520
1.08
0.19
1.3
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
223
1.12
0.18
1.2
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
153
0.85
0.18
1.5
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
60
1.17
0.18
1.1
1.3
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
22
195
1.13
0.17
1.2
1.2
—
634.0
—
0
5
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
22
195
1.13
0.17
1.1
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
110
1.18
0.17
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
66
0.76
0.17
1.2
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
148
1.15
0.17
1.5
1.5
nmol/l
1.2
0.8
0.36
11
121
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.4
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
28
254
1.11
0.16
3.3
3.2
nmol/l
0.9
0.8
0.23
22
208
(3025941) Bacteria identified in Stool by Culture
38
411
0.92
0.16
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
943
0.95
0.16
3.6
3.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
266
0.90
0.16
1.1
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
80
0.75
0.15
1.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
80
0.75
0.15
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
80
0.75
0.15
1.2
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
119
0.84
0.15
1.1
1.5
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
9
83
1.09
0.14
1.1
1.1
g/l
1.6
1.6
—
9
74
(3003740) Influenza virus B Ag [Presence] in Specimen
7
86
0.81
0.14
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
7
86
0.81
0.14
1.0
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
90
0.78
0.14
1.1
1.7
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
12
103
1.17
0.13
1.0
1.1
—
15.1
—
0
6
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
151
1.13
0.13
1.1
1.3
miu/ml
252.5
241.5
—
6
59
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
263
0.91
0.13
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
263
0.91
0.13
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
180
1.11
0.13
1.3
1.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
11
94
1.17
0.13
1.1
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
40
374
1.07
0.13
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
108
0.83
0.13
1.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
24
262
0.91
0.12
2.0
1.7
mg/l
1.5
3.0
1.68
19
200
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
152
1.12
0.12
1.1
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
95
1.16
0.11
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
22
203
1.09
0.09
1.8
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
12
134
0.89
0.08
1.2
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
19
206
0.92
0.08
3.5
3.5
mg/l
20.4
25.6
—
10
126
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
56
1.07
0.08
1.3
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
728
7319
0.98
0.08
20.5
16.3
%
38.8
38.9
0.06
450
4890
(3032773) Endomysium IgG Ab [Titer] in Serum
7
66
1.06
0.08
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
73
0.82
0.07
1.2
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
6
74
0.81
0.07
4.2
3.5
mg/l
29.3
16.0
—
6
57
(3025130) Human papilloma virus identified in Specimen
8
76
1.05
0.07
2.4
1.9
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
286
0.94
0.07
1.5
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
85
0.82
0.07
1.1
1.2
nmol/l
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
88
1.02
0.07
1.0
1.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
19
177
1.07
0.06
3.2
2.5
%
15.3
15.8
0.22
12
86
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
104
0.86
0.06
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
483
1.04
0.06
1.1
1.2
iu/ml
73.5
142.0
1.33
19
184
(3003338) MCHC [Mass/volume]
670
6729
0.99
0.05
25.4
19.4
g/l
330.8
331.2
0.67
661
6659
(3021589) Normoblasts [#/volume] in Blood
367
3645
1.01
0.04
11.4
9.5
e9/l
0.0
0.0
1.21
311
2989
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
49
479
1.02
0.03
1.7
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
11
102
1.08
0.03
3.1
3.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
12
128
0.94
0.02
1.6
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
120
1189
1.01
0.02
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
127
0.94
0.01
1.5
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
378
0.98
0.01
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
217
0.97
0.01
1.1
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
206
0.97
0.00
1.4
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
23
224
1.03
0.00
1.3
1.8
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
15
146
1.03
0.00
2.4
3.3
e9/l
3.9
4.4
0.37
15
146
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
15
152
0.99
0.00
2.7
3.6
%
58.3
59.2
0.12
15
152
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
114
1144
1.00
0.00
2.9
3.0
ug/l
0.7
0.8
0.29
73
774
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
10
99
1.01
0.00
1.2
1.2
nmol/l
0.7
0.7
—
10
91
(3002385) Erythrocyte distribution width [Ratio]
670
6698
1.00
0.00
23.1
18.2
%
13.9
13.8
1.04
658
6526
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
12
123
0.98
0.00
1.5
1.2
u/ml
720.8
275.9
—
5
75
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
199
1.01
0.00
1.8
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
199
1.01
0.00
1.8
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
283
0.99
0.00
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
32
323
0.99
0.00
2.3
2.6
—
—
—
0
0
(4281824)
11
115
0.96
0.00
1.0
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
63
0.95
0.00
1.2
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44813793)
5
50
1.00
0.00
1.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.7
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
9
90
1.00
0.00
1.0
1.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
4.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
1.5
—
0
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
82
0.98
0.00
1.1
1.8
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
89
1.01
0.00
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
5
53
0.94
0.00
1.4
1.6
—
1839.9
—
0
11
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
60
1.00
0.00
1.0
1.3
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
11.8
—
0
9
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
65
0.92
0.00
1.0
1.1
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
190.4
—
0
5
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
74
0.95
0.00
1.1
1.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint G6_MEDLEOTH and mortality.

Females

Parameter HR [95% CI] p-value
G6_MEDLEOTH 0.892 [0.75, 1.07] 0.212
Birth year 0.998 [0.99, 1.01] 0.646

During the follow-up period (1.1.1998 — 31.12.2019), 141 out of 1512 females with G6_MEDLEOTH died.

Males

Parameter HR [95% CI] p-value
G6_MEDLEOTH 1.025 [0.82, 1.28] 0.823
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 169 out of 1159 males with G6_MEDLEOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_MEDLEOTH.

N-year risk Females Males
1 0.081% 0.187%
5 0.625% 1.053%
10 1.59% 2.713%
15 2.958% 4.969%
20 5.052% 8.629%

Relationships between endpoints

↥

Index endpoint: G6_MEDLEOTH – Other lesions of median nerve

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data